SEC Form 4 · accession 0001518669-16-000008
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
D. Jamie Macdonald
Officer — Chief Executive Officer · Director
Period of report
Sep 27, 2016
Accepted (ET)
Sep 28, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Sep 27, 2016 | S | 13,989 | $44.301 | D | 62,220 | D | |
| Class A Common StockF3 | Sep 27, 2016 | S | 3,293 | $44.313 | D | 58,927 | D | |
| Class A Common Stock | Sep 27, 2016 | M | 17,752 | $13.52 | A | 76,679 | D | |
| Class A Common StockF4 | Sep 27, 2016 | S | 17,752 | $44.307 | D | 58,927 | D | |
| Class A Common Stock | Sep 27, 2016 | M | 18,936 | $16.06 | A | 77,863 | D | |
| Class A Common StockF5 | Sep 27, 2016 | S | 18,936 | $44.3005 | D | 58,927 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F6 | $13.52 | Sep 27, 2016 | M | 17,752 | D | — | Apr 1, 2024 | Class A Common Stock | 17,752 | 71,005 | D |
| Stock Option (Right to Buy Class A Common Stock)F7 | $16.06 | Sep 27, 2016 | M | 18,936 | D | — | Jun 30, 2024 | Class A Common Stock | 18,936 | 75,738 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2016.
- F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $43.98 to $44.74, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F3The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $43.96 to $44.59, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.99 to $44.66, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $43.96 to $44.66, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F6One half of the shares subject to this option vest yearly in five equal installments beginning on April 1, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.
- F7One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.